CLL, Chronic Lymphocytic Leukemia, What is the significance of
IGHV mutations and how they are assessed. Presented by
Jennifer Brown, M.D., Ph.D., Director of the CLL Center and the
Dana-Farber Cancer Institute.
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.